PathAI
Digital Pathology
8 open rolesDigital PathologyBoston, United States400 employees$355M raisedEst. 2016
General Catalyst
General Atlantic
D1 Capital Partners
Kaiser Permanente
Bristol Myers Squibb
Labcorp
About PathAI
- PathAI is dedicated to improving patient outcomes with AI-powered pathology and meaningful collaboration with biopharma, laboratories and clinicians.
- Their platform promises substantial improvements to the accuracy of diagnosis and provides end-to-end data-driven pathology analysis.
PathAI is listed on Rocketlist with 8 active roles. The company is categorized as Digital Pathology in HealthTech. PathAI is at Series C stage, with a B2B business model, headquartered in Boston, United States. PathAI was founded in 2016 and has 400 employees. PathAI has raised $355M. Active roles are refreshed daily from public hiring sources.